Abstract
Through case studies, the authors point out environmental and hereditary factors that contribute to increased risk of developing endometrial cancer and how to apply screening modalities in pre- and postmenopausal women. Attention is drawn to certain anatomic abnormalities that prevent vaginal bleeding – the most common symptom related to cancer. Diagnostic tests that are available to pursue various aspects of the diagnosis in a sequential fashion are described, culminating in the endometrial biopsy. Recommendations for screening and diagnosis in the asymptomatic as well as the symptomatic patients are summarized. Surgical staging represents the final event in the diagnostic workup. Instances when such staging can be modified to deal with various comorbidities are delineated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer Statistics 2006. CA Cancer J Clin 2006; 56:106–130.
Hale GE, Hughes CL, Cline JM. Endometrial cancer: hormonal factors, the perimenopausal “window at risk”, and isoflavones. J Clin Endocrinol Metab 2002; 87:3.
Coulam CB, Anneger JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983; 61:403.
Azziz R, Woods KS, Reyna R, et al The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89:2745.
Schlechte J, Sherman B, Halmi N, et al. Prolactin-secreting pituitary tumors in amenorrheic women: a comparative study. Endocr Rev 1980; 1:295.
Outwater EK, Wagner BJ, Mannion C, et al Sex cord-stromal and steroid cell tumors of the ovary. Radiographics 1998; 18:1523.
Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr 1987; 45:277.
Persson I, Adami H-O, Bergkvist L, et al Risk of endometrial cancer after treatment with estrogens alone or in conjunction with progestogens: results of a prospective study. BMJ 1989; 298:147.
Zumoff B, Fishman J, Gallagher TF, Hellman L. Estradiol metabolism in cirrhosis.J Clin Invest 1968; 47(1):20–25.
Cohen I. Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecol Oncol 2004; 94:256.
Suh-Burgmann EJ, Goodman A. Surveillance for endometrial cancer in women receiving tamoxifen. Ann Intern Med 1999; 131:127–135.
Fisher B, Constantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM. Endometrial cancer in tamoxifen treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994; 86:527–537.
ACOG Commitee Opinior Number 232 April 2000-Tomoxifen and Endometrial Cancer.
Ollikainen M, Abdel-Rahman WM, Moisio AL, et al Molecular analysis of familial endometrial carcinoma: a manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome? J Clin Oncol 2005; 23:4609.
Schmeler KM, Lynch HT, Chen L-M, et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch Syndrome. N Eng J Med 2006; 354:261–269.
Levine DA, Lin O, Barakat RR, et al. Risk of endometrial carcinoma associated with BRCA mutation. Gynecol Oncol 2001; 80:395.
Kleinerman RA, Boice JD, Storm HH, et al. Second primary cancer after treatment for cervical cancer. Cancer 1995; 76:442–452.
Anderson B. Diagnosis of endometrial cancer. Clin Obstet Gynecol 1986; 13:739–750.
Pellerin GP, Finan MA. Endometrial cancer in women 45 years of age or younger: a clinicopathological analysis. Am J Obstet Gynecol 2005; 193:1640.
Cherkis RC, Patten SF, Jr, Andrews TJ, et al. Significance of normal endometrial cells detected by cervical cytology. Obstet Gynecol 1988; 71:242.
Cherkis RC, Patten SF, Jr, Dickinson JC, et al Significance of atypical endometrial cells detected by cervical cytology. Obstet Gynecol 1987; 69:786.
DuBeshter B, Warshal DP, Angel C, et al. Endometrial carcinoma: the relevance of cervical cytology. Obstet Gynecol 1991; 77:458.
Chang A, Sandweiss L, Bose S. Cytologically benign endometrial cells in the papanicolaou smears of postmenopausal women. Gynecol Oncol 2001; 80:37.
Clark TJ, Mann CH, Shah N, Khan KS, Song F, Gupta JK. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review. BJOG: An Int J Obstet & Gynaecol 2002; 109:313
Karlsson B, Granberg S, Wikland M, et al Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding – a Nordic multicenter study. Am J Obstet Gynecol 1995; 172:1488.
Decensi A, Fontana V, Bruno S, Gustavino C, Gatteschi B, Costa A. Effect of tamoxifen on endometrial proliferation. J Clin Oncol 1996; 14:434–440.
Love CDB, Muir BB, Scrimgeour JB, et al Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol 1999; 17:2050.
Schwartz LB, Snyder J, Horan C, Porges RF, Nachtigall LE, Goldstein SR. The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen. Ultrasound Obstet Gynecol 1998; 11:48–53.
Manfredi R, Gui B, Maresca G, Fanfaui F, Bonomo L. Endometrial cancer: magnetic resonance imaging. Abdom Imaging 2005; 30:626–636.
Novak E. A suction-curet apparatus endometrial biopsy. JAMA 1935; 104:1497–1498.
Behnamfar F, Khamehchian T, Mazoochi T, Fahiminejad T. Diagnostic value of endometrial sampling with pipelle suction curettage for identifying endometrial lesions in patients with abnormal uterine bleeding. J Res Med Sci 2004; 3:21–23.
Goldberg GL, Tsalacopoulos G, Davey DA. A comparison of endometrial sampling with the Accurette and Vabra aspirator and uterine curettage. S Afr Med J 1982; 61:114–116.
International Federation of Gynecology and Obstetrics. Annual report on the results of treatment in gynecologic cancer. Int J Gynecol Obstet 1989; 28:189–190.
Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. Cancer 1987; 60:2035–2041.
Aquino-Parsons C, Lim P, Wong F, Mildenberger M. Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO stage Ia and Ib endometrial adenocarcinoma: treatment implications. Gynecol Oncol 1998; 71:83–86.
Goff BA, Rice LW. Assessment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol 1990; 38:46–48.
Acog Partice bulleten, number 65, August 2005. Management of Endometrial Cancer
Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojian F, III, et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995; 56:29–33.
Fowler JM. Laparoscopic staging of endometrial cancer. Clin Obstet Gynecol 1996; 39:669.
Soliman PT, Slomovitz BM, Broaddus RR, et al. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol 2004; 94:456.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Goodman, A., Goff, B. (2009). Endometrial Cancer. In: Oliva, E., Muggia, F. (eds) Uterine Cancer. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-60327-044-1_2
Download citation
DOI: https://doi.org/10.1007/978-1-60327-044-1_2
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-58829-736-5
Online ISBN: 978-1-60327-044-1
eBook Packages: MedicineMedicine (R0)